Category: Joint ventures/collaborations
-
Pfizer Licenses University Institute’s Obesity Research
The global pharmaceutical company Pfizer is funding research at Université de Montréal in Quebec, Canada to identify cellular pathways in genetic defects leading to therapies for early-onset morbid obesity. Financial aspects of the collaboration, which gives Pfizer a license to commercially develop results of the research, were not disclosed. Pfizer is funding and licensing research…
-
AbbVie, Galapagos Partner on Cystic Fibrosis Therapies
The pharmaceutical companies AbbVie in North Chicago, Illinois and Galapagos NV in Mechelen, Belgium are collaborating on development and marketing of treatments for the inherited disease cystic fibrosis. The deal, with a total potential value of at least $405 million, covers discovery, development, and commercialization of compounds addressing defective genetic mutations associated with the disease.…
-
Engineered Castor Beans Growth-Tested as Biofuel Feedstock
The plant genomics company Evogene Ltd. in Rehovot, Israel says growing trials of its engineered castor bean show it is ready for commercial development as an alternative feedstock for biodiesel fuels and other industrial products. The three-year trials were conducted in Brazil with SLC Agrícola S.A., a grower of soybeans, corn, and cotton. Evogene’s biofuel…
-
Fox Foundation, Companies Create Research Tools Group
The Michael J. Fox Foundation for Parkinson’s Research in New York and seven companies are joining in a consortium to systematize development and sharing of tools for studying Parkinson’s disease. The seven companies are Amicus Therapeutics, ApoPharma, Biogen Idec, Eli Lilly and Company, Pfizer, PsychoGenics and Upsher-Smith Laboratories. The group, called the Parkinson’s Disease Research Tools…
-
Near-Infrared Light Tests Paintings’ Ability to Travel
A collaboration of British, Spanish, and Slovenian chemistry researchers and fine art conservation specialists devised a technique adapted from the life sciences to test the ability of paintings to withstand the rigors of travel without damaging the works of art. The team led by Matija Strlic of the Centre for Sustainable Heritage at University College London…
-
Princeton Lab, USDA Partner on Egg Pasteurization Process
Engineers from Princeton Plasma Physics Laboratory in Plainsboro, New Jersey and agricultural scientists from the U.S. Department of Agriculture research lab in Wyndmoor, Pennsylvania developed a process and device for pastuerizing eggs in the shell without damaging the delicate egg white. The team inventing the process filed for a patent and is seeking licensees to…
-
University, Company Partner on Computer-Based Drug Discovery
The drug discovery company Serometrix in Pittsford, New York is deploying bioinformatics software developed by University of Strathclyde in Glasgow, Scotland for identifying protein structures that show subtle clues as potential targets for drugs. Financial terms of of the licensing agreement were not disclosed. The system is a result of a collaboration between Strathclyde chemistry…
-
Fuel Cells for Refrigerated Trucks Under Development
A project combining the efforts of Pacific Northwest National Laboratory (PNNL) in Richland, Washington with two fuel cell manufacturers is developing fuel cells to power the refrigeration units in refigerated trucks. The companies — Nuvera Fuel Cells in Billerica,, Massachusetts and Plug Power Inc. in Latham, New York — each received a $650,000 matching contract…
-
Trial Testing Rose Bengal Compound as Melanoma Treatment
A new clinical trial at Moffitt Cancer Center in Tampa, Florida is testing a compound derived from rose bengal, a dye for diagnosing eye disorders, as an injectable treatment for melanoma, a form of skin cancer. The early-stage trial is conducted with Provectus Pharmaceuticals in Knoxville, Tennessee that is commercializing the compound, known as PV-10.…
-
Diagnostics Developer, Mt. Sinai to Partner on Biomarkers
Exosome Diagnostics and Mount Sinai medical center, both in New York, are collaborating on the discovery of genetic biomarkers to build diagnostics for inflammation, cancer, and other diseases. Financial aspects of the five-year agreement were not disclosed. Exosome Diagnostics develops diagnostics based on biomarkers derived from bodily fluids, such as blood, urine, plasma, serum, and…
You must be logged in to post a comment.